Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis

INTRODUCTION: On-treatment HCV RNA measurements are crucial for the prediction of a sustained virological response (SVR) and to determine treatment futility during protease inhibitor-based triple therapies. In patients with advanced liver disease an accurate risk/benefit calculation based on reliabl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Maasoumy, Benjamin, Hunyady, Bela, Calvaruso, Vincenza, Makara, Mihály, Vermehren, Johannes, Haragh, Attila, Susser, Simone, Bremer, Birgit, Cloherty, Gavin, Manns, Michael P., Craxì, Antonio, Wedemeyer, Heiner, Sarrazin, Christoph
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2014
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229112/
https://ncbi.nlm.nih.gov/pubmed/25389779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0110857
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares